ASBMR-RBDA Symposium: Ilofotase Alfa Shows Benefits for Hypophosphatasia
The American Society for Bone and Mineral Research (ASBMR) and Rare Bone Disease Alliance (RBDA) held the annual Symposium on Rare Bone Diseases this year on October 12. During…